SEER · Seer, Inc. · Metrics
Market Cap
$107.98M
Shares
55.37M
SEER metrics
70 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$1.95
Market cap
$107.98M
Price action
20 metricsPrice change (1W)
+0.0%
Price change (30D)
-3.9%
Price change (3M)
+13.4%
Price change (6M)
+7.7%
Price change (YTD)
+6.6%
Price change (1Y)
-5.3%
Trailing year
Price change (5Y)
-95.5%
52-week high
$2.37
52-week low
$1.62
Change from 52-week high
-17.7%
Change from 52-week low
+20.4%
Annualized volatility
54.1%
Annualized volatility (3M)
78.6%
Beta
0.9
RSI (14D)
41.2
Price vs SMA 50
-5.8%
Price vs SMA 200
+3.0%
Avg volume (3M)
1.05M
Relative volume
0.1
Average dollar volume
$2.18M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
55.37M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
7.6×
reciprocal yield 13.2%
P / book
0.5
reciprocal yield 209.0%
FCF yield
-41.0%
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
—
Earnings yield
-62.9%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-11
Profitability
9 metricsGross margin
47.7%
Operating margin
-498.2%
Trailing 12 months
Net margin
-478.0%
Gross profit (TTM)
$6.78M
Operating profit (TTM)
−$70.83M
Net income (TTM)
−$67.96M
Trailing 12 months
Diluted EPS (TTM)
$-1.29
FCF margin
-311.1%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-23.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$14.22M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-4.3%
Year over year · fewer shares
Revenue CAGR (3Y)
+2.3%
Revenue CAGR (5Y)
+90.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-30.1%
Return on assets
-26.5%
Debt / equity
—
Current ratio
14.7
EBITDA (TTM)
−$66.18M
Free cash flow (TTM)
−$44.23M
Quick ratio
14.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$26.07M
Latest balance sheet
Cash & equivalents
$26.07M
Total assets
$256.64M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$43.38M
Capital expenditures (TTM)
$854,000
R&D (TTM)
$37.55M
SG&A (TTM)
$40.05M
Stock compensation (TTM)
$10.57M
R&D / revenue
264.1%
Stock compensation / revenue
74.3%
Ownership (13F)
3 metrics13F filers
59
13F filer change QoQ
+1
Institutional ownership
37.0%
Short interest
3 metricsShort interest
0.3%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
42 / 100
Insider activity
2 metricsNet insider buying (90D)
−$38,075
Insider-sentiment score
52 / 100
Risk flags
1 metricsGoing concern
—